NCT00685269View on ClinicalTrials.gov

Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Obstructive Sleep Apnea Syndrome
Interventions
DRUG

Eszopiclone

Eszopiclone 3 mg QD

DRUG

Placebo

Placebo tablet

Trial Locations (2)

Unknown

Atlanta

Cincinnati

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00685269 - Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS) | Biotech Hunter | Biotech Hunter